Thermo Fisher Scientific (TMO)☆

Thermo Fisher Scientific is a leading supplier of laboratory instruments, reagents, and life-science services. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.

Thermo Fisher Scientific trades on the NYSE under the ticker symbol TMO. As of the most recent market data, the stock was priced around $617.10, down 0.82% on the session, giving Thermo Fisher Scientific a market capitalization of roughly $228.17B.

Over the past 52 weeks, TMO has traded between $435.27 and $647.00. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 33.4, a common gauge of how richly the market prices the company's earnings. Thermo Fisher Scientific also pays a dividend, currently yielding around 30.00%.

As one of the larger companies in the Health Care sector, Thermo Fisher Scientific is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch TMO for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.

Because the S&P 500 is weighted by market value, Thermo Fisher Scientific's size means its share-price moves can also nudge the index as a whole, making TMO a stock that even index investors pay attention to.